ALURD (Allurion Technologies) Piotroski F-Score: 2 (As of Jun. 24, 2026) — Near Median


ALURD Allurion Technologies Inc ALURD
16 GF Score
Price $5.91
GF Value $10.66
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Allurion Technologies Piotroski F-Score?

Allurion Technologies ALURD -2.11% 16 Piotroski F-Score is 2 as of Jun. 24, 2026, which is at its 10-year median of 2.00. GuruFocus rates ALURD with a GF Score™ of 16/100 and a GF Value™ of $10.66 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Allurion Technologies ranks worse than 90.56% on this metric.

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Allurion Technologies has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Allurion Technologies's Piotroski F-Score or its related term are showing as below:

ALURD' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 2   Max: 3
Current: 2

During the past 5 years, the highest Piotroski F-Score of Allurion Technologies was 3. The lowest was 1. And the median was 2.

Allurion Technologies  (OTCPK:ALURD) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Allurion Technologies Piotroski F-Score Related Terms


Allurion Technologies Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Allurion Technologies's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Allurion Technologies Piotroski F-Score Chart

Allurion Technologies Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
N/A N/A 3.00 2.00 2.00

Allurion Technologies Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 2.00 1.00 2.00 2.00

ALURD vs ALRTF, VVOS, SINT: Piotroski F-Score Comparison

For the Medical Devices subindustry, Allurion Technologies's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allurion Technologies Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Allurion Technologies's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Allurion Technologies's Piotroski F-Score falls into.


ALURD
16GF Score
Allurion Technologies Inc ALURD
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -9.335 + -11.884 + -6.035 + -6.095 = $-33.35 Mil.
Cash Flow from Operations was -7.613 + -6.544 + -5.32 + -3.221 = $-22.70 Mil.
Revenue was 3.379 + 2.658 + 3.613 + 2.947 = $12.60 Mil.
Gross Profit was 2.497 + 1.304 + 1.608 + 1.229 = $6.64 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(38.414 + 28.169 + 18.141 + 15.772 + 13.995) / 5 = $22.8982 Mil.
Total Assets at the begining of this year (Mar25) was $38.41 Mil.
Long-Term Debt & Capital Lease Obligation was $0.46 Mil.
Total Current Assets was $11.30 Mil.
Total Current Liabilities was $37.26 Mil.
Net Income was -8.322 + 8.736 + -9.608 + -1.501 = $-10.70 Mil.

Revenue was 11.766 + 5.367 + 5.591 + 5.58 = $28.30 Mil.
Gross Profit was 8.993 + 3.111 + 2.533 + 4.161 = $18.80 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(59.988 + 46.55 + 50.699 + 32.813 + 38.414) / 5 = $45.6928 Mil.
Total Assets at the begining of last year (Mar24) was $59.99 Mil.
Long-Term Debt & Capital Lease Obligation was $32.15 Mil.
Total Current Assets was $33.17 Mil.
Total Current Liabilities was $15.90 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Allurion Technologies's current Net Income (TTM) was -33.35. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Allurion Technologies's current Cash Flow from Operations (TTM) was -22.70. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-33.349/38.414
=-0.86814703

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-10.695/59.988
=-0.17828566

Allurion Technologies's return on assets of this year was -0.86814703. Allurion Technologies's return on assets of last year was -0.17828566. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Allurion Technologies's current Net Income (TTM) was -33.35. Allurion Technologies's current Cash Flow from Operations (TTM) was -22.70. ==> -22.70 > -33.35 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=0.455/22.8982
=0.01987056

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=32.146/45.6928
=0.70352441

Allurion Technologies's gearing of this year was 0.01987056. Allurion Technologies's gearing of last year was 0.70352441. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=11.304/37.258
=0.30339793

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=33.166/15.897
=2.08630559

Allurion Technologies's current ratio of this year was 0.30339793. Allurion Technologies's current ratio of last year was 2.08630559. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Allurion Technologies's number of shares in issue this year was 0.89. Allurion Technologies's number of shares in issue last year was 0.319. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=6.638/12.597
=0.52695086

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=18.798/28.304
=0.66414641

Allurion Technologies's gross margin of this year was 0.52695086. Allurion Technologies's gross margin of last year was 0.66414641. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=12.597/38.414
=0.32792732

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=28.304/59.988
=0.4718277

Allurion Technologies's asset turnover of this year was 0.32792732. Allurion Technologies's asset turnover of last year was 0.4718277. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+1+0+0+0+0
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Allurion Technologies has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 2 mean?
Allurion Technologies (ALURD) has a Piotroski F-Score of 2 as of Jun. 24, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Allurion Technologies and its competitors. This is near median its historical median of 2.00. Over the past decade, Allurion Technologies' Piotroski F-Score has ranged from 1.00 to 3.00. According to the industry distribution chart, Allurion Technologies ranks #729 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 90.6%.
Is Allurion Technologies' Piotroski F-Score too high?
Allurion Technologies' current Piotroski F-Score of 2 is near median its 10-year median of 2.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 3.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Allurion Technologies' value of 2 is 60% below this industry median. Based on the distribution chart, Allurion Technologies ranks #729 out of 805 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Allurion Technologies has a GF Score™ of 16/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Allurion Technologies' Piotroski F-Score compare to ALRTF and VVOS?
According to the Medical Devices & Instruments industry distribution chart, Allurion Technologies ranks #729 out of 805 companies for Piotroski F-Score. This places Allurion Technologies in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Allurion Technologies' value of 2 is 60% below this benchmark. Historically, Allurion Technologies' own Piotroski F-Score has ranged from 1.00 to 3.00 over the past decade. While the company's 10-year median is 2.00 vs. the industry median of 5.00, Allurion Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Allurion Technologies's current Piotroski F-Score of 2 is 60% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Allurion Technologies and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Allurion Technologies's current Piotroski F-Score is 2, which is near median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Allurion Technologies stock overvalued right now?
Based on GuruFocus' analysis, Allurion Technologies (ALURD) is currently considered Possible Value Trap. The stock's GF Value™ is $10.66, compared to a current price of $5.91 — trading 44.6% below its estimated fair value. The current Piotroski F-Score is 2, which is near median its 10-year median of 2.00 and 60% below the Medical Devices & Instruments industry median of 5.00. Allurion Technologies' overall GF Score™ is 16/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Allurion Technologies (ALURD), the current Piotroski F-Score is 2 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Allurion Technologies (ALURD) Overvalued in 2026?

Based on GuruFocus' analysis, Allurion Technologies stock appears to be undervalued. The current stock price of $5.91 is trading 44.6% below its estimated GF Value™ of $10.66. GuruFocus considers Allurion Technologies to be Possible Value Trap.

Key valuation signals for ALURD:

  • Piotroski F-Score: 2 (near median its 10-year median of 2.00)
  • GF Value™: $10.66 vs. price of $5.91 (44.6% below fair value)
  • GF Score™: 16/100 with 4 warning signs
  • Industry Position: 60% below the Medical Devices & Instruments median (#729 of 805)

No single metric tells the full story. See the ALURD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Allurion Technologies Business Description

Address 11 Huron Drive, Natick, MA, USA, 01760
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.
16GF Score

Get the complete analysis for ALURD

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.91
Price
$10.66
GF Value